(Q36073567)

12 August 2017

Protective effects of a glutathione disulfide mimetic (NOV-002) against cisplatin induced kidney toxicity (English)

1 reference

12 August 2017

1 reference

5

Danyelle M Townsend

1 reference

12 August 2017

4

Kenneth D Tew

1 reference

12 August 2017

Sara Jenderny

1

1 reference

12 August 2017

He Lin

series ordinal

2

1 reference

12 August 2017

Tracy Garrett

series ordinal

3

1 reference

12 August 2017

17 October 2009

1 reference

Biomedicine and Pharmacotherapy

12 August 2017

1 reference

12 August 2017

64

1 reference

12 August 2017

1

1 reference

12 August 2017

73-76

1 reference

Role of glutathione S-transferase Pi in cisplatin-induced nephrotoxicity

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388846

NOV-002, a glutathione disulfide mimetic, as a modulator of cellular redox balance

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388846

Metabolism of Cisplatin to a nephrotoxin in proximal tubule cells.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388846

Inhibition of gamma-glutamyl transpeptidase or cysteine S-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388846

High pressure liquid chromatography and mass spectrometry characterization of the nephrotoxic biotransformation products of Cisplatin.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388846

Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388846

Phase I trial of cisplatin in combination with glutathione

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388846

NOV-002, a mimetic of glutathione disulfide

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388846

Glutathione in the prevention of cisplatin induced toxicities. A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancer

5 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19896793

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumour activity of cisplatin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19896793

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.BIOPHA.2009.09.009

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

19896793

1 reference